| Phase 01 trial |
|
Phase 0
|
NCT06710899 |
Jan → Aug 2027 expected |
urinary tract infection |
University Hospitals of North Midlands NHS Trust |
Not yet recruiting
|
No outcome recorded
|
| Phase 22 trials · 1 met primary |
|
Phase 2
|
NCT07202949 |
Feb 2026 → Oct 2027 expected |
urinary tract infection |
University College, London |
Recruiting
|
No outcome recorded
|
|
Phase 2
|
NCT03818321 |
Jun 2019 → Jul 2021 |
pelvic organ prolapse, urinary tract infection, urinary tract obstruction |
TriHealth Inc. |
Completed
|
Met primary
|
| Phase 44 trials · 1 met primary |
|
Phase 4
|
NCT06953271 |
May 2025 → May 2026 overdue |
overactive bladder, urinary tract infection |
Women and Infants Hospital of Rhode Island |
Not yet recruiting
|
No outcome recorded
|
|
Phase 4
|
NCT04709601 |
Jan 2021 → Dec 2024 |
urinary tract infection |
University of Texas Southwestern Medical Center |
Terminated
|
No outcome recorded
|
|
Phase 4
|
NCT04077580 |
Nov 2019 → Jun 2023 |
urinary tract infection |
University of Oslo |
Completed
|
Met primary
|
|
Phase 4
|
NCT03996057 |
Jun 2018 → Feb 2022 |
female reproductive system disorder, urinary tract infection |
Washington University School of Medicine |
Withdrawn
|
No outcome recorded
|
| Phase not applicable1 trial |
| — |
NCT02358993 |
Dec 2014 → Sep 2020 |
prosthesis-related infectious disease, urinary tract infection |
University of Pennsylvania |
Completed
|
No outcome recorded
|
| Comparator or background therapy1 trial |
|
Phase 4
|
NCT03077711 Comparator |
Jun 2016 → Jun 2019 |
urinary tract infection |
Endeavor Health |
Completed
|
No outcome recorded
|